tradingkey.logo
tradingkey.logo
Search

Rockwell Medical Inc

RMTI
Add to Watchlist
5.190USD
+4.639+842.78%
Close 07/01, 16:00ETQuotes delayed by 15 min
204.85MMarket Cap
LossP/E TTM

More Details of Rockwell Medical Inc Company

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

Rockwell Medical Inc Info

Ticker SymbolRMTI
Company nameRockwell Medical Inc
IPO dateJan 27, 1998
CEOStrobeck (Mark)
Number of employees244
Security typeOrdinary Share
Fiscal year-endJan 27
Address30142 Wixom Road
CityWIXOM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code48393
Phone18004493353
Websitehttps://www.rockwellmed.com/
Ticker SymbolRMTI
IPO dateJan 27, 1998
CEOStrobeck (Mark)

Company Executives of Rockwell Medical Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
--
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
145.45K
+3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
125.68K
-1.94%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
--
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.95K
-165.85%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
61.85K
-124.77%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
18.68K
-449.49%
Mr. Robert S. Radie
Mr. Robert S. Radie
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Allen R. Nissenson, M.D.
Dr. Allen R. Nissenson, M.D.
Independent Director
Independent Director
--
--
Ms. Heather R. Hunter
Ms. Heather R. Hunter
Chief Operating Officer
Chief Operating Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
--
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
145.45K
+3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
125.68K
-1.94%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
--
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.95K
-165.85%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
61.85K
-124.77%

FAQs

Who are the top five shareholders of Rockwell Medical Inc?

The top five shareholders of Rockwell Medical Inc are: Mr. Mark H. Ravich

How many institutions hold shares of Rockwell Medical Inc (RMTI)?

As of 2026Q1, 98 institutions hold shares of Rockwell Medical Inc, with a combined market value of approximately 5.15M, accounting for 13.04% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -2200637.00.